R2技術公司(Sunnyvale, CA, USA)是一家乳腺癌和其他疾病早期診斷計算機輔助檢查(CAD)技術開發商，已經宣布與GE健康保健公司(St. Giles, UK)達成了一項多年協議。

根據這項協議，GE醫療保健公司將，在美國以外GE國際市場銷售R2具有知識產權的ImageChecker D乳房X線檢查CAD系統，GE Senographe 2000D、Senographe DS全視野數字乳房X線檢查(FFDM)系統，以及新型Senographe Essential FFDM系統(在供應市場的時候)。

CAD Systems to Be Distributed by GE Healthcare
 
R2 Technology, Inc. (Sunnyvale, CA, USA), a developer of computer-aided detection (CAD) technology for the early detection of breast cancer and other medical disorders, has announced a multi-year agreement with GE Healthcare (St. Giles, UK).

Under the agreement, GE Healthcare will distribute R2’s proprietary ImageChecker D mammography CAD system with the GE Senographe 2000D, Senographe DS full-field digital mammography (FFDM) systems in GE’s international markets outside the United States, and the new GE Senographe Essential FFDM system (when commercially available).